Thomas Moriarty - Providence Business News

Home Tags Thomas Moriarty

CVS, Walgreens announce opioid settlements totaling $10B

Economic Activity 11/02/2022

WOONSOCKET (AP) – CVS Health Corp. and Walgreen Co. announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits nationwide...

A GROWING PORTFOLIO: The ever-changing health care landscape puts CVS Health and Thomas Moriarty at the center of complex and difficult public- and corporate-policy discussions, a reality that “energizes” the company’s chief policy & external affairs officer. / PBN PHOTO/MICHAEL SALERNO

Vision, nimbleness crucial for CVS

Business Services 04/28/2017

Thomas Moriarty | CVS Health Corp., chief policy & external affairs officer and general counsel Americans know health care is a complicated and challenging topic...

THE CAREER ACHIEVER honoree for the 2017 C-Suite Awards program, Enzo Rebula, addresses the crowd at the Omni Providence Hotel Thursday.

FM Global founding exec leads C-Suite Award winners event

PBN Award Winners 04/28/2017

PROVIDENCE – Enzo Rebula, who as head of human resources was charged with knitting together four companies into what would become FM Global, received...

- Featured Event -

Latest News

A FEDERAL APPEALS COURT on Friday ruled that the controversial truck tolling program used for the state’s RhodeWorks bridge infrastructure initiative can partially remain in place. PBN FILE PHOTO/MICHAEL SALERNO

Federal appeals court partially upholds R.I. truck-tolling program

12/06/2024

Union representing Women & Infants caregivers ratifies labor contract with ‘groundbreaking’...

12/06/2024

R.I. sports betting growth stagnates while other states on upswing

12/06/2024

CVS HEALTH CORP. has entered an underwriting agreement to sell $3 billion in outstanding notes.

SEC filing of the week: CVS agrees to sell $3B in...

12/06/2024

Electric Boat workers returning after evacuation due to bomb threat

12/06/2024

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.